In 2023, the American Academy of Pediatrics published a clinical practice guideline recommending weight-loss medications, including glucagon-like peptide-1 (GLP-1) receptor agonists, as a supplement ...

She’s racing to a run-through for a 14-course tasting menu she will barely nibble at as she raves about her weight loss on ...

If you've been scrolling through TikTok recently, you might have come across the "winter arc" trend — a sort of fresh take on ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Several years ago, a little-known drug named Ozempic—previously used only to treat diabetes—emerged as a promising new drug ...

Polycystic ovary syndrome (PCOS) is a hormonal disorder commonly diagnosed in women of childbearing age. While PCOS isn’t an ...

Ozempic, Zepbound, Wegovy, and other GLP-1 medications have transformed the way we lose weight. People who take them report life-changi ...

Weight loss drugs catapulted many into a new wellness era, and gave hope to those with diabetes, obesity and who struggled to lose weight. The global anti-obesity drugs market — including the ...

Weight loss and good health is a New Year's resolution for many going into 2025 - and it turns out there's a berry out there to offer a helping hand in their journey. Scientific research has ...

including the number one branded oral weight loss medication CONTRAVE ® (naltrexone HCl/bupropion HCl), today announces 2024 over-performance for revenue, demand and achievement of key ...

Contrave stands out in the weight loss drug market for its potential to improve weight management while also addressing obesity-related cardiovascular risks. Backed by substantial patient research, ...

Contrave (naltrexone/bupropion) is a prescription drug used for weight loss and long-term weight management in certain adults. The drug is prescribed along with diet ...